Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending August 3, 2024 (Week 31)
Reporting Area Chlamydia trachomatis infection §
Current weekPrevious 52 weeks Max †Cum YTD 2024 †Cum YTD 2023 †
U.S. Residents, excluding U.S. Territories 14,138 35,196 799,226 993,817
New England 161 1,172 20,231 32,132
Connecticut - 318 - 7,798
Maine 46 81 1,566 1,748
Massachusetts - 647 14,049 17,136
New Hampshire - 76 1,317 1,665
Rhode Island 89 389 2,526 2,955
Vermont 26 33 773 830
Middle Atlantic 2,076 4,379 107,450 118,954
New Jersey 441 788 18,070 21,419
New York (excluding New York City) 762 957 23,112 24,970
New York City - 1,565 35,390 39,916
Pennsylvania 873 1,168 30,878 32,649
East North Central 1,615 4,704 95,064 136,446
Illinois 2 1,497 17,212 42,056
Indiana 380 720 17,988 20,769
Michigan 175 1,020 16,982 25,294
Ohio 640 1,153 29,077 33,358
Wisconsin 418 533 13,805 14,969
West North Central 958 2,118 52,244 58,118
Iowa 144 313 6,996 8,234
Kansas 136 304 7,038 8,080
Minnesota 105 486 11,550 13,053
Missouri 420 724 17,588 18,286
Nebraska 36 246 4,780 5,454
North Dakota 42 87 1,801 2,056
South Dakota 75 118 2,491 2,955
South Atlantic 3,371 12,279 201,136 228,452
Delaware - 227 3,031 3,390
District of Columbia - 191 3,728 5,101
Florida 1,786 6,935 65,357 67,346
Georgia - 1,534 38,031 44,347
Maryland - 1,016 16,375 21,199
North Carolina 2 1,434 29,913 39,861
South Carolina 704 820 19,615 19,821
Virginia 848 934 22,611 24,804
West Virginia 31 115 2,475 2,583
East South Central 1,009 2,748 35,869 65,026
Alabama 639 895 19,192 20,332
Kentucky 252 592 9,302 9,657
Mississippi 118 1,006 7,375 12,264
Tennessee - 1,313 - 22,773
West South Central 1,180 4,708 108,451 136,175
Arkansas 196 398 9,543 11,021
Louisiana 359 799 19,497 21,939
Oklahoma 61 422 5,974 11,885
Texas 564 3,265 73,437 91,330
Mountain 945 2,691 57,952 69,363
Arizona 433 929 22,449 24,369
Colorado - 857 12,903 15,478
Idaho 41 127 3,006 3,498
Montana 49 98 1,949 2,175
Nevada 190 357 6,540 9,360
New Mexico 5 256 4,279 6,722
Utah 199 255 5,966 6,636
Wyoming 28 52 860 1,125
Pacific 2,823 5,124 120,829 149,151
Alaska 76 125 2,912 3,098
California 2,165 3,947 99,387 116,136
Hawaii - 146 - 3,795
Oregon 258 382 8,242 9,106
Washington 324 609 10,288 17,016
U.S. Territories - 135 667 3,047
American Samoa - 0 - -
Commonwealth of Northern Mariana Islands - 0 - -
Guam - 0 - -
Puerto Rico - 135 667 3,047
U.S. Virgin Islands - 0 - -
Non-U.S. Residents - 3 16 35
Total 14,138 35,240 799,909 996,899
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • * Case counts for reporting years 2023 and 2024 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/data-statistics/readers-guides/.
  • † Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Beginning in January 2022, only confirmed cases are published to align with the approved CSTE position statement 21-ID-06, whereas in previous years, all case classification statuses were published. This change may cause a decrease in published case counts when compared to previous years.